Which has stronger earnings and valuation, TELA or HYPR?

Hyperfine has lower revenue, but higher earnings than TELA Bio. Hyperfine is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.28M 0.49 -$38.83M -$0.79 N/A Hyperfine $11.40M 12.02 -$35.57M -$0.41 N/A

Is TELA or HYPR more profitable?

TELA Bio has a net margin of -49.30% compared to Hyperfine's net margin of -226.88%. Hyperfine's return on equity of -98.83% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Hyperfine -226.88% -98.83% -67.09%

Which has stronger earnings and valuation, CVRX or TELA?

TELA Bio has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 2.52 -$53.31M -$2.02 N/A TELA Bio $80.28M 0.49 -$38.83M -$0.79 N/A

Is CVRX or TELA more profitable?

TELA Bio has a net margin of -49.30% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -89.14% -120.76% -48.38% TELA Bio -49.30% -1,320.81% -55.83%

Is TELA or SNWV more profitable?

Sanuwave Health has a net margin of 35.96% compared to TELA Bio's net margin of -49.30%. Sanuwave Health's return on equity of -450.56% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Sanuwave Health 35.96% -450.56% 44.87%

Is TELA or MBOT more profitable?

Microbot Medical has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Microbot Medical's return on equity of -21.84% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Microbot Medical N/A -21.84% -20.71%

Which has preferable valuation and earnings, TELA or NNOX?

TELA Bio has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.28M 0.49 -$38.83M -$0.79 N/A Nano-X Imaging $13.02M 10.32 -$75.02M -$1.59 N/A

Is TELA or NNOX more profitable?

TELA Bio has a net margin of -49.30% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Nano-X Imaging -790.87% -64.65% -57.27%

TELA Bio (TELA) Competitors

$0.88 0.00 (-0.10%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$0.88 0.00 (-0.01%)

As of 06/5/2026 07:33 PM Eastern

Compare

TELA vs. HYPR, CVRX, SNWV, MBOT, and NNOX

Should you buy TELA Bio stock or one of its competitors? MarketBeat compares TELA Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TELA Bio include Hyperfine (HYPR), CVRx (CVRX), Sanuwave Health (SNWV), Microbot Medical (MBOT), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry.

How does TELA Bio compare to Hyperfine?

TELA Bio (NASDAQ:TELA) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

TELA Bio currently has a consensus price target of $2.20, suggesting a potential upside of 149.97%. Hyperfine has a consensus price target of $1.78, suggesting a potential upside of 29.23%. Given TELA Bio's stronger consensus rating and higher possible upside, equities research analysts clearly believe TELA Bio is more favorable than Hyperfine.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

TELA Bio has a beta of 1.33, suggesting that its share price is 33% more volatile than the broader market. Comparatively, Hyperfine has a beta of 1.38, suggesting that its share price is 38% more volatile than the broader market.

In the previous week, Hyperfine had 2 more articles in the media than TELA Bio. MarketBeat recorded 2 mentions for Hyperfine and 0 mentions for TELA Bio. Hyperfine's average media sentiment score of 0.42 beat TELA Bio's score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media.

Company	Overall Sentiment
TELA Bio	Neutral
Hyperfine	Neutral

TELA Bio has a net margin of -49.30% compared to Hyperfine's net margin of -226.88%. Hyperfine's return on equity of -98.83% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Hyperfine	-226.88%	-98.83%	-67.09%

Hyperfine has lower revenue, but higher earnings than TELA Bio. Hyperfine is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.49	-$38.83M	-$0.79	N/A
Hyperfine	$11.40M	12.02	-$35.57M	-$0.41	N/A

94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by insiders. Comparatively, 26.3% of Hyperfine shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Hyperfine beats TELA Bio on 8 of the 15 factors compared between the two stocks.

How does TELA Bio compare to CVRx?

CVRx (NASDAQ:CVRX) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, media sentiment, profitability, analyst recommendations, institutional ownership and valuation.

TELA Bio has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	2.52	-$53.31M	-$2.02	N/A
TELA Bio	$80.28M	0.49	-$38.83M	-$0.79	N/A

TELA Bio has a net margin of -49.30% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
TELA Bio	-49.30%	-1,320.81%	-55.83%

75.3% of CVRx shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 13.9% of CVRx shares are owned by company insiders. Comparatively, 4.7% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CVRx presently has a consensus price target of $11.50, suggesting a potential upside of 113.75%. TELA Bio has a consensus price target of $2.20, suggesting a potential upside of 149.97%. Given TELA Bio's higher probable upside, analysts plainly believe TELA Bio is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

CVRx has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, TELA Bio has a beta of 1.33, suggesting that its stock price is 33% more volatile than the broader market.

In the previous week, CVRx had 1 more articles in the media than TELA Bio. MarketBeat recorded 1 mentions for CVRx and 0 mentions for TELA Bio. CVRx's average media sentiment score of 0.00 equaled TELA Bio'saverage media sentiment score.

Company	Overall Sentiment
CVRx	Neutral
TELA Bio	Neutral

Summary

TELA Bio beats CVRx on 9 of the 16 factors compared between the two stocks.

How does TELA Bio compare to Sanuwave Health?

TELA Bio (NASDAQ:TELA) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

94.4% of TELA Bio shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 4.7% of TELA Bio shares are held by company insiders. Comparatively, 14.4% of Sanuwave Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Sanuwave Health has a net margin of 35.96% compared to TELA Bio's net margin of -49.30%. Sanuwave Health's return on equity of -450.56% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Sanuwave Health	35.96%	-450.56%	44.87%

TELA Bio currently has a consensus price target of $2.20, indicating a potential upside of 149.97%. Sanuwave Health has a consensus price target of $51.00, indicating a potential upside of 245.53%. Given Sanuwave Health's stronger consensus rating and higher possible upside, analysts plainly believe Sanuwave Health is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, TELA Bio's average media sentiment score of 0.00 equaled Sanuwave Health'saverage media sentiment score.

Company	Overall Sentiment
TELA Bio	Neutral
Sanuwave Health	Neutral

TELA Bio has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market.

Sanuwave Health has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.49	-$38.83M	-$0.79	N/A
Sanuwave Health	$44.05M	2.88	$11.81M	$0.33	44.73

Summary

Sanuwave Health beats TELA Bio on 12 of the 15 factors compared between the two stocks.

How does TELA Bio compare to Microbot Medical?

TELA Bio (NASDAQ:TELA) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Microbot Medical has lower revenue, but higher earnings than TELA Bio. Microbot Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.49	-$38.83M	-$0.79	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Microbot Medical has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Microbot Medical's return on equity of -21.84% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Microbot Medical	N/A	-21.84%	-20.71%

94.4% of TELA Bio shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 4.7% of TELA Bio shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Microbot Medical had 1 more articles in the media than TELA Bio. MarketBeat recorded 1 mentions for Microbot Medical and 0 mentions for TELA Bio. TELA Bio's average media sentiment score of 0.00 equaled Microbot Medical'saverage media sentiment score.

Company	Overall Sentiment
TELA Bio	Neutral
Microbot Medical	Neutral

TELA Bio has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market.

TELA Bio currently has a consensus price target of $2.20, suggesting a potential upside of 149.97%. Microbot Medical has a consensus price target of $6.63, suggesting a potential upside of 260.05%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts clearly believe Microbot Medical is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Summary

Microbot Medical beats TELA Bio on 10 of the 15 factors compared between the two stocks.

How does TELA Bio compare to Nano-X Imaging?

TELA Bio (NASDAQ:TELA) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

TELA Bio has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.49	-$38.83M	-$0.79	N/A
Nano-X Imaging	$13.02M	10.32	-$75.02M	-$1.59	N/A

TELA Bio has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market.

94.4% of TELA Bio shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 4.7% of TELA Bio shares are held by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

TELA Bio has a net margin of -49.30% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

In the previous week, Nano-X Imaging had 2 more articles in the media than TELA Bio. MarketBeat recorded 2 mentions for Nano-X Imaging and 0 mentions for TELA Bio. TELA Bio's average media sentiment score of 0.00 equaled Nano-X Imaging'saverage media sentiment score.

Company	Overall Sentiment
TELA Bio	Neutral
Nano-X Imaging	Neutral

TELA Bio currently has a consensus price target of $2.20, suggesting a potential upside of 149.97%. Nano-X Imaging has a consensus price target of $5.00, suggesting a potential upside of 159.07%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

Summary

TELA Bio beats Nano-X Imaging on 9 of the 16 factors compared between the two stocks.

Get TELA Bio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TELA vs. The Competition

Export

Metric	TELA Bio	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$39.40M	$3.34B	$6.68B	$11.99B
Dividend Yield	N/A	2.30%	2.67%	5.55%
P/E Ratio	-1.11	10.33	20.29	21.86
Price / Sales	0.49	300.34	519.33	112.45
Price / Cash	N/A	116.33	42.23	54.60
Price / Book	5.50	6.51	9.73	6.35
Net Income	-$38.83M	$24.19M	$3.57B	$337.59M
7 Day Performance	-9.27%	-6.96%	-1.26%	-2.51%
1 Month Performance	-11.10%	-4.27%	0.82%	-0.69%
1 Year Performance	-53.43%	36.81%	24.09%	25.37%

TELA Bio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TELA TELA Bio	2.7632 of 5 stars	$0.88 -0.1%	$2.20 +150.0%	-54.9%	$39.40M	$80.28M	N/A	120
HYPR Hyperfine	3.0431 of 5 stars	$1.54 +1.0%	$1.78 +16.2%	+59.8%	$154.86M	$11.40M	N/A	190	Gap Up
CVRX CVRx	2.0004 of 5 stars	$5.44 +0.1%	$11.50 +111.6%	-16.7%	$148.07M	$56.65M	N/A	160
SNWV Sanuwave Health	1.6477 of 5 stars	$15.32 -3.4%	$51.00 +233.0%	-46.9%	$141.62M	$44.05M	47.54	40
MBOT Microbot Medical	2.1539 of 5 stars	$1.99 +0.3%	$7.50 +277.8%	-31.3%	$136.35M	N/A	N/A	20	Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TELA) was last updated on 6/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TELA Bio (TELA) Competitors

TELA vs. HYPR, CVRX, SNWV, MBOT, and NNOX

How does TELA Bio compare to Hyperfine?

Summary

How does TELA Bio compare to CVRx?

Summary

How does TELA Bio compare to Sanuwave Health?

Summary

How does TELA Bio compare to Microbot Medical?

Summary

How does TELA Bio compare to Nano-X Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA vs. The Competition

TELA Bio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TELA Bio (TELA) Competitors

TELA vs. HYPR, CVRX, SNWV, MBOT, and NNOX

How does TELA Bio compare to Hyperfine?

Do analysts recommend TELA or HYPR?

Which has more volatility and risk, TELA or HYPR?

Does the media favor TELA or HYPR?

Is TELA or HYPR more profitable?

Which has stronger earnings and valuation, TELA or HYPR?

Do institutionals and insiders hold more shares of TELA or HYPR?

Summary

How does TELA Bio compare to CVRx?

Which has stronger earnings and valuation, CVRX or TELA?

Is CVRX or TELA more profitable?

Do institutionals & insiders hold more shares of CVRX or TELA?

Do analysts prefer CVRX or TELA?

Which has more volatility & risk, CVRX or TELA?

Does the media refer more to CVRX or TELA?

Summary

How does TELA Bio compare to Sanuwave Health?

Do insiders & institutionals have more ownership in TELA or SNWV?

Is TELA or SNWV more profitable?

Do analysts prefer TELA or SNWV?

Does the media prefer TELA or SNWV?

Which has more risk and volatility, TELA or SNWV?

Which has stronger earnings & valuation, TELA or SNWV?

Summary

How does TELA Bio compare to Microbot Medical?

Which has higher valuation & earnings, TELA or MBOT?

Is TELA or MBOT more profitable?

Do institutionals & insiders have more ownership in TELA or MBOT?

Does the media prefer TELA or MBOT?

Which has more volatility and risk, TELA or MBOT?

Do analysts recommend TELA or MBOT?

Summary

How does TELA Bio compare to Nano-X Imaging?

Which has preferable valuation and earnings, TELA or NNOX?

Which has more volatility and risk, TELA or NNOX?

Do insiders and institutionals hold more shares of TELA or NNOX?

Is TELA or NNOX more profitable?

Does the media refer more to TELA or NNOX?

Do analysts prefer TELA or NNOX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA vs. The Competition

TELA Bio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools